Candidate Genes on Chromosome 9q33-34 Involved in the Progression of Childhood Ependymomas
- 10 April 2009
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 27 (11) , 1884-1892
- https://doi.org/10.1200/jco.2007.15.4195
Abstract
Purpose The molecular pathogenesis of pediatric ependymoma remains unclear. Our study was designed to identify genetic changes implicated in ependymoma progression. Patients and Methods We characterized 59 ependymoma samples (33 at diagnosis and 26 at relapse) using array-comparative genomic hybridization (aCGH). Specific chromosomal imbalances were confirmed by fluorescent in situ hybridization, and candidate genes were assessed by real-time quantitative polymerase chain reaction (qPCR), immunohistochemistry, sequencing, and in vitro functional studies. Results aCGH analysis revealed a significant increase in genomic imbalances on relapse compared with diagnosis, such as gain of 9qter and 1q (54% v 21% and 12% v 0%, respectively) and loss of 6q (27% v 6%). Supervised tumor classification showed that gain of 9qter was associated with tumor recurrence, age older than 3 years, and posterior fossa location. Using a candidate-gene strategy, we found an overexpression of two potential oncogenes at the locus 9q...Keywords
This publication has 37 references indexed in Scilit:
- Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective studyThe Lancet Oncology, 2007
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- Identification of Gains on 1q and Epidermal Growth Factor Receptor Overexpression as Independent Prognostic Markers in Intracranial EpendymomaClinical Cancer Research, 2006
- Predicting which children are at risk for ependymoma relapseJournal of Neuro-Oncology, 2006
- EpendymomaChild's Nervous System, 2003
- Genomic Imbalances in Pediatric Intracranial Ependymomas Define Clinically Relevant GroupsThe American Journal of Pathology, 2002
- Postoperative Chemotherapy Without Irradiation for Ependymoma in Children Under 5 Years of Age: A Multicenter Trial of the French Society of Pediatric OncologyJournal of Clinical Oncology, 2001
- Chromosomal Abnormalities Subdivide Ependymal Tumors into Clinically Relevant GroupsThe American Journal of Pathology, 2001
- Karyotype Studies in 18 Ependymomas with Literature Review of 107 CasesCancer Genetics and Cytogenetics, 1999
- Intracranial ependymomas in children: A critical review of prognostic factors and a plea for cooperationMedical and Pediatric Oncology, 1998